Biogen | BIIB - Trade Creditors


Biogen reported $403.9M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Merck USD 3.83B 36M Jun/2026
Moderna USD 167M 6M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 23.6B 888M Jun/2026
Sanofi EUR 22.71B 219M Mar/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026